GSK
GSK
GSK
880 hedge funds and large institutions have $12B invested in GSK in 2024 Q2 according to their latest regulatory filings, with 76 funds opening new positions, 308 increasing their positions, 303 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $13.3B → $12B (-$1.34B)
12% less first-time investments, than exits
New positions opened: 76 | Existing positions closed: 86
29% less funds holding in top 10
Funds holding in top 10: 14 → 10 (-4)
Holders
880
Holding in Top 10
10
Calls
$172M
Puts
$109M
Top Buyers
| 1 | +$84.8M | |
| 2 | +$80.8M | |
| 3 | +$78.5M | |
| 4 |
Primecap Management
Pasadena,
California
|
+$68.3M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$67.1M |
Top Sellers
| 1 | -$117M | |
| 2 | -$91M | |
| 3 | -$70.8M | |
| 4 |
Citigroup
New York
|
-$67.6M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$55.9M |